The most successful outcomes come from people who take a systems-level approach, optimizing nutrition, managing their GLP-1 dosing thoughtfully, supporting their body with evidence-based compounds, and giving the process the time it requires
Unlike store-bought products, our GHK-Cu creams and serums are compounded in a regulated pharmacy, ensuring purity, concentration, and effectiveness
New AASM treatment guidelines recommend against the long-term use of dopaminergic drugs to treat RLS, as they may worsen symptoms
Conclusions and Relevance GLP-1 RA therapy in IIH is associated with significant reductions in medication use, symptoms/signs, and procedural interventions, suggesting its potential as a management strategy
Retatrutide does not currently hold a UK marketing authorisation and is not available through NHS prescribing pathways